Member Info for daveycaferacer

It's interesting to note that Healthcare was the only sector forecast to grow in H2 2020. All other sectors have contracted significantly:-

https://www.reuters.com/article/us-usa-earnings-graphic/global-presence-an-advantage-as-u-s-companies-brace-for-second-half-slump-idUSKCN24M10H

It's interesting to note that Healthcare was the only sector forecast to grow in H2 2020. All other sectors have contracted significantly:-

https://www.reuters.com/article/us-usa-earnings-graphic/global-presence-an-advantage-as-u-s-companies-brace-for-second-half-slump-idUSKCN24M10H

agreed, and with bed & ISA you do not technically sell and re-buy anyway

I agree, wonderful news, and a rapidly expanding pipeline, if only the market would price it accordingly. Personally I still see this as a $20bn mcap Company by the end of the decade! It has to get there, my retirement depends on it....

The AGM was on the 16th and the Chairman said that the meeting an update will be forthcoming "within the next 14 days"

I have! - checkout Stocktwits

U.S Market has tanked so everything is down regardless

Steeplejack - I tend to agree with you on this, and I have to say I am not a fan of the ATM, I'd rather have a good old fashioned dilutive placing where the market reacts in a big way but then it's over, rather than the constant drip fed placing which is effectively what an ATM is.

Interesting stats from the recently published Evaluate World Pharma report

• Oncology is the area with the largest proportion of clinical development spending, with 37.4% of total pipeline expenditure and 28.7% of total pipeline FDA approvals. Oncology will contribute 21.7% of total pharmaceutical sales in 2026, with immuno-oncology sales increasing to $94.7bn between 2019-26 at a CAGR of 20.2%.

or the Brits like me who happen to hold ADR's in my American 401K pension and my UK SIPP!!

"whats the final sp target we looking for here£2.50?"

£25 because I will be invested for 10 years

Not only do we have the imminent news on StemprintER we've also had many hints from the CEO that a major collaboration deal with big Pharma is likely to occur soon to, and that could be even bigger news ......

The record date is the date you need to be on the share register - if you sell your shares the day afterwards you would still benefit from shares in the Newco as you would have been on the share Register on the Record date

The flip-flopping rainbow chasing herd coming back in for a couple of days to pick up their Stem shares - more flip flops than Bournemouth Beach!

That's wishful thinking in the extreme !

From Monday for those who have not seen it, Emma Ulker discusses what she describes as the ground-breaking approach Tiziana Life Sciences

https://www.proactiveinvestors.co.uk/companies/news/924595/tiziana-life-sciences-has-potential-to--revolutionise-treatment-in-monoclonal-antibodies-market--924595.html

Yes but Foralumab is the only fully-human monoclonal anti-CD3 antibody, I think there are CD6's etc but not CD3.

indeed, within 14 days, which mean people have got a week left, maximum but the news could come at any time.

Also, we our CEO could not have dropped any more hints that a big pharma deal is coming too and that could be a bigger event that the StemprintER divestment in my view.

As a seasoned Biotech and Pharma Investor I can tell you:-

shortly = 1 day to 1 year
imminently = 1 year to 5 years
soon = 5 to 10 years

I agree whimax, aside from StemprintER the CEO has already stated it would be prudent and smart to join hands with other Companies to expedite the development of the leading drug candidates.

By that I suspect he means a major licensing and co-development deal with a big Pharma player. Those types of deals usually include a large upfront payment + development milestones and royalties.